Reputable clinic "albert Einstein" has developed the world’s first genetic test for determination of coronavirus. This was announced on Thursday, the portal G1.
According to the information resource, the precision analysis was patented in the U.S. in the international patent system world organization for intellectual property (PCT), and starting in June it will become available for the diagnosis of infection. Through the development of Brazilian scientists is the technology new-generation sequencing to analyze small DNA fragments to determine the disease. To recognize SARS-CoV-2, the researchers adapted this technique for working with RNA is present in viruses of different types, explains the portal.
According to the developers, the test has 100% accuracy and eliminates the possibility of false positive results. While its efficiency is comparable to PCR tests that are now used for the detection of coronavirus. In addition, this is the first genetic test that can be used for mass diagnostics because it can simultaneously explore 1 536 samples – 16 times more than in PCR testing.
As a biomaterial can be used in saliva or nasopharyngeal secret. The result of the study prepared three days, said the portal.
